Please login to the form below

Not currently logged in
Email:
Password:

infections

This page shows the latest infections news and features for those working in and with pharma, biotech and healthcare.

Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%

Lilly’s antibody bamlanivimab cuts COVID-19 risk by up to 80%

Eli Lilly’s has announced that its neutralising antibody bamlanivimab significantly reduced the risk of COVID-19 infection among residents and staff in care homes.

Latest news

More from news
Approximately 8 fully matching, plus 1,030 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 75 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 23 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 52 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Lynx Group

We are the Havas Lynx Group. Devoted to fresh thinking. Changing the way the world does healthcare communications for the...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics